Nymox Pharmaceutical Corp (NYMX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Nymox Pharmaceutical Corp (NYMX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7373
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:Bahamas
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the diagnosis of Alzheimer’s disease. Its diagnostic product portfolio includes NicAlert test to determine smoking status; and TobacAlert home test to determine person’s level of exposure to tobacco products, including second hand smoke. Nymox’s lead drug candidate, NX-1207 intended for the treatment of BPH (benign prostatic hyperplasia) and certain types of cancer. It has subsidiaries in New Jersey, the US. Nymox is headquartered in Nassau, the Bahamas.

Nymox Pharmaceutical Corp (NYMX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Nymox Pharmaceutical Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Nymox Pharmaceutical Corp, Medical Equipment, Deal Details 14
Equity Offering 14
Nymox Pharma Raises USD2.24 Million in Private Placement of Shares 14
Nymox Pharmaceutical to Raise USD12 Million in Private Placement 15
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 16
Nymox Pharma Raises USD0.59 Million in Private Placement of Shares 17
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 18
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 19
Nymox Pharma Raises USD0.25 Million in Private Placement of Shares 20
Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 21
Nymox Pharma Raises USD0.15 million in Private Placement of Shares 22
Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 23
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 24
Nymox Pharma Raises USD0.3 million in Private Placement of Shares 25
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 26
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 27
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 28
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 29
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 30
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 31
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 32
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 33
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 34
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 35
Nymox Pharma Raises USD0.3 million in Private Placement of Shares 36
Nymox Pharma Raises USD0.14 Million in Private Placement of Shares 37
Nymox Pharma Raises USD0.15 Million in Public Offering of Shares 38
Nymox Pharma Raises USD0.35 Million in Public Offering of Shares 39
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 40
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 41
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 42
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 43
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 44
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 45
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 46
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 47
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 48
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 49
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 50
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 51
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 52
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 53
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 54
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 55
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 56
Nymox Pharma Raises USD1.1 Million in Private Placement of Shares 57
Nymox Pharma Raises USD1 Million in Private Placement of Shares 58
Nymox Pharma Raises USD1 Million in Private Placement of Shares 59
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 60
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 61
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 62
Nymox Pharma Raises USD1 Million in Private Placement of Shares 63
Nymox Pharmaceutical Corp – Key Competitors 64
Nymox Pharmaceutical Corp – Key Employees 65
Nymox Pharmaceutical Corp – Locations And Subsidiaries 66
Head Office 66
Other Locations & Subsidiaries 66
Recent Developments 67
Other Significant Developments 67
Jul 02, 2018: NYMOX Announces Expanded Marketing Plans 67
Appendix 68
Methodology 68
About GlobalData 68
Contact Us 68
Disclaimer 68

List of Tables
Nymox Pharmaceutical Corp, Medical Equipment, Key Facts, 2017 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Nymox Pharmaceutical Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Nymox Pharmaceutical Corp, Deals By Market, 2012 to YTD 2018 10
Nymox Pharmaceutical Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Nymox Pharma Raises USD2.24 Million in Private Placement of Shares 14
Nymox Pharmaceutical to Raise USD12 Million in Private Placement 15
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 16
Nymox Pharma Raises USD0.59 Million in Private Placement of Shares 17
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 18
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 19
Nymox Pharma Raises USD0.25 Million in Private Placement of Shares 20
Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 21
Nymox Pharma Raises USD0.15 million in Private Placement of Shares 22
Nymox Pharma Raises USD0.15 Million in Private Placement of Shares 23
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 24
Nymox Pharma Raises USD0.3 million in Private Placement of Shares 25
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 26
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 27
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 28
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 29
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 30
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 31
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 32
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 33
Nymox Pharma Raises USD0.1 Million in Private Placement of Shares 34
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 35
Nymox Pharma Raises USD0.3 million in Private Placement of Shares 36
Nymox Pharma Raises USD0.14 Million in Private Placement of Shares 37
Nymox Pharma Raises USD0.15 Million in Public Offering of Shares 38
Nymox Pharma Raises USD0.35 Million in Public Offering of Shares 39
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 40
Nymox Pharma Raises USD0.35 Million in Private Placement of Shares 41
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 42
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 43
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 44
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 45
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 46
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 47
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 48
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 49
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 50
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 51
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 52
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 53
Nymox Pharma Raises USD0.3 Million in Private Placement of Shares 54
Nymox Pharma Raises USD0.4 Million in Private Placement of Shares 55
Nymox Pharma Raises USD0.2 Million in Private Placement of Shares 56
Nymox Pharma Raises USD1.1 Million in Private Placement of Shares 57
Nymox Pharma Raises USD1 Million in Private Placement of Shares 58
Nymox Pharma Raises USD1 Million in Private Placement of Shares 59
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 60
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 61
Nymox Pharma Raises USD0.5 Million in Private Placement of Shares 62
Nymox Pharma Raises USD1 Million in Private Placement of Shares 63
Nymox Pharmaceutical Corp, Key Competitors 64
Nymox Pharmaceutical Corp, Key Employees 65
Nymox Pharmaceutical Corp, Subsidiaries 66

List of Figures
Nymox Pharmaceutical Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Nymox Pharmaceutical Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Nymox Pharmaceutical Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Nymox Pharmaceutical Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

★海外企業調査レポート[Nymox Pharmaceutical Corp (NYMX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Engie SA (ENGI):電力:M&Aディール及び事業提携情報
    Summary Engie SA (Engie) is an electric utility. It provides electricity, natural gas, and energy services. It generates electricity from hydro, wind, biomass, and solar sources, and trades and sells that energy; supplies, distributes, trades, and sells natural gas; and offers a comprehensive range …
  • China Petroleum & Chemical Corporation (Sinopec):戦略・SWOT・企業財務分析
    China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Ovid Therapeutics Inc (OVID):製薬・医療:M&Aディール及び事業提携情報
    Summary Ovid Therapeutics Inc (Ovid Therapeutics) is a bio-pharmaceutical company which identifies, discovers, and develops medicines for neurological disorders. The company’s pipeline products are indicated for diseases such as Angelman Syndrome and Fragile X Syndrome. It develops, assess, commerci …
  • PerkinElmer Inc (PKI):企業の財務・戦略的SWOT分析
    PerkinElmer Inc (PKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Petroleos de Venezuela SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • YGM Trading Ltd.:戦略・SWOT・企業財務分析
    YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report Summary YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Elektrizitatswerk der Stadt Zurich:電力:M&Aディール及び事業提携情報
    Summary Elektrizitatswerk der Stadt Zurich (EWZ) is an alternative energy company that offers power and energy network services. The company’s services include power and energy supplying and distribution, contact and advice, fault messages, invoice and payment, online consulting and document center …
  • Oblong Inc (OBLG):企業の財務・戦略的SWOT分析
    Oblong Inc (OBLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • KSS Line Ltd (044450):企業の財務・戦略的SWOT分析
    Summary KSS Line Ltd (KSS), formerly Korea Special Shipping Co Ltd, is a provider of marine transportation services for liquefied petroleum gas and petrochemical products. It operates through gas and chemical business lines. Its gas cargoes include anhydrous ammonia, butadiene, butane, butane1, c4 r …
  • Pall Corp-医療機器分野:企業M&A・提携分析
    Summary Pall Corp (Pall), a subsidiary of Danaher Corporation, is a supplier of filtration, separation and purification products and technologies to remove solid, liquid and gaseous contaminants from liquids and gases. Its major products include biochemicals, bioreactors, breathers, canisters, cartr …
  • The Boeing Co (BA):企業の財務・戦略的SWOT分析
    The Boeing Co (BA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Hasbro, Inc.:企業の戦略・SWOT・財務情報
    Hasbro, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hasbro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Manitou Bf Sa
    Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report Summary Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Universal Biosensors Inc (UBI):企業の財務・戦略的SWOT分析
    Universal Biosensors Inc (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Wacker Neuson Se
    Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report Summary Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ping An Insurance (Group) Company of China, Ltd.:企業のM&A・事業提携・投資動向
    Ping An Insurance (Group) Company of China, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ping An Insurance (Group) Company of China, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • iBio Inc (IBIO):企業の財務・戦略的SWOT分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Anheuser-Busch InBev NVSA (ABI):企業の財務・戦略的SWOT分析
    Anheuser-Busch InBev NVSA (ABI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Fintel Energia Group SpA (FTL):企業の財務・戦略的SWOT分析
    Summary Fintel Energia Group SpA (Fintel) is a utility service provider that supplies electricity and natural gas. The company's services include designing, consultation, and installation of technologies and system of production of renewable energies for the Group and to third parties. It also provi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆